IgA Anti-β2-Glycoprotein I Autoantibodies Are Associated with an Increased Risk of Thromboembolic Events in Patients with Systemic Lupus Erythematosus
Nadera Sweiss(University of Illinois Chicago), Jerrold S. Levine(Illinois College), Ronghai Bo(University of Southern California), Anthony Chang(University of Chicago), Maria Badaracco(University of Chicago), Reena Kapadia(University of Southern California), Farzan Mahmood(University of Cincinnati), Mary F. Smaron(University of Chicago), Suncica Volkov(University of Illinois Chicago), Joseph M. Baron(University of Chicago), Deborah Manst(Loyola University Chicago), Tara Ballav Adhikari(University of Washington)
Cited by 57
Related Papers
Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
|The Lancet|2018|3.6k
Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
|The Lancet Infectious Diseases|2018|2k
Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017
|The Lancet|2018|1.2k
The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool.
|PubMed|2014|505
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial
|Annals of the Rheumatic Diseases|2010|503